TSCAN THERAPEUTICS INC. - COMMON STOCK

2.8500

08-January-25 15:56:45

15 minutes delayed

Stocks

-0.1600

-5.32%

Today's range

2.7900 - 3.0000

ISIN

N/A

Source

NASDAQ

TScan Therapeutics to Participate in the Chardan 5th Annual Genetic Medicines Conference

28 Sep 2021 07:00:00 By Nasdaq GlobeNewswire
TScan Therapeutics Appoints Zoran Zdraveski, J.D., Ph.D. as Chief Legal Officer

09 Sep 2021 16:05:00 By Nasdaq GlobeNewswire
TScan Therapeutics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

02 Sep 2021 07:00:01 By Nasdaq GlobeNewswire
TScan Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress

19 Aug 2021 07:00:01 By Nasdaq GlobeNewswire
TScan Therapeutics to Present Discovery of T Cell Targets for COVID-19 at the Cell-Mediated Therapies for Infectious Disease Summit

21 Jul 2021 07:00:01 By Nasdaq GlobeNewswire
TScan Therapeutics, Inc. Announces Pricing of Initial Public Offering

15 Jul 2021 18:59:22 By Nasdaq GlobeNewswire

<<
<
2
3
4
5
6
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.